Annamycin is a synthetic anthracycline antibiotic that functions as a DNA intercalator and topoisomerase II inhibitor, currently under clinical investigation for its potential in treating relapsed or refractory… Read more
Annamycin is a synthetic anthracycline antibiotic that functions as a DNA intercalator and topoisomerase II inhibitor, currently under clinical investigation for its potential in treating relapsed or refractory acute myeloid leukemia and other malignancies. To support the rigorous demands of pharmaceutical quality control, this category provides high-quality reference standards essential for analytical testing. These compounds are critical for researchers performing impurity profiling, allowing for the precise identification and quantification of degradation products or synthesis-related impurities. Furthermore, the inclusion of stable isotope labelled compounds, such as Annamycin-d3, provides researchers with reliable internal standards for sophisticated mass spectrometry techniques like LC-MS/MS. By utilizing these materials in method validation and bioanalytical studies, laboratories can ensure the sensitivity, accuracy, and regulatory compliance necessary for drug development and ongoing stability testing throughout the product lifecycle.